Twist Bioscience (TWST) Other Non-Current Assets (2018 - 2026)

Twist Bioscience has disclosed Other Non-Current Assets across 9 years of filings, most recently posting $5.4 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets rose 47.14% year-over-year to $5.4 million; the TTM figure through Mar 2026 stood at $5.4 million (up 47.14% YoY), while the FY2025 annual figure was $4.9 million, up 74.08% from the prior year.
• Other Non-Current Assets rose to $5.4 million in Q1 2026, from $2.4 million in the prior quarter.
• Over the last five years, Other Non-Current Assets for TWST reached as high as $5.4 million in Q1 2026 and fell as low as $1.6 million in Q1 2022.
• The 5-year median for Other Non-Current Assets is $2.8 million (2023), against an average of $3.1 million.
• Annual changes were most pronounced in 2022 — Other Non-Current Assets tumbled 67.54% — and 2023, when it surged 178.56%.
• A 5-year view of Other Non-Current Assets shows it stood at $2.4 million in 2022, then grew by 18.13% to $2.8 million in 2023, then rose by 21.0% to $3.4 million in 2024, then sank by 30.51% to $2.4 million in 2025, then surged by 126.98% to $5.4 million in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $5.4 million, $2.4 million, and $4.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.